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ABSTRACT: This study evaluated the effect of combined treatment of aqueous extracts of Tetracarpidium 
conophorum (TCE) nuts and Vernonia amygdalina (VAE) leaves on some biochemical parameters such as amylase 
activity, urea and creatinine in alloxan induced diabetic Wistar rats. Forty two (42) Wistar rats with weight range of 125-
275g were grouped into 6 groups of 7 rats in each group. The first group served as the normal control while the 
remaining five groups were induced with diabetes using alloxan at 120 mg/kg body weight.  Group two served as 
diabetic control and the remaining groups were treated with 500 mg/kg TCE, 500 mg/kg VAE, combined extract of 500 
mg/kg TCE and 500 mg/kg VAE and 7.69 mg/kg metformin respectively. The rats were treated orally once daily for 28 
days. Three rats per group were sacrificed on the 14th and 28th day of treatment. The plasma levels of glucose, amylase, 
urea and creatinine were measured. The result showed that there was a reduction (p<0.05) in the blood glucose level of 
all the treated groups compared to the diabetic control. The results also showed that urea and creatinine were (p<0.05) 
decreased in all treated groups compared to the untreated diabetic group. The histology of the pancreas of treated groups 
showed that the plant extracts ameliorated   the effect of alloxan on the organ. In conclusion, the combined aqueous 
extracts of Tetracarpidium conophorum nuts and Vernonia amygdalina leaves reduced the level of damage to the kidney 
and pancreas when administered to diabetic rats at the dosage used in this study. © JASEM 
https://dx.doi.org/10.4314/jasem.v21i5.15 
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Diabetes mellitus is a chronic condition that occurs 
when the body cannot produce enough or effectively 
use insulin (Chineye, et al., 2011). Insulin is a 
hormone produced by the pancreas that allows 
glucose (and other nutrients) from food to enter into 
the cells of the body where it is converted into energy 
required by tissue and muscle to function. 
Diabetes mellitus is one of the leading causes of 
death in developed countries today and it is 
technically defined as a metabolic disorder that is 
characterized by chronic hyperglycemia, absolute or 
relative lack of disturbance of carbohydrate, fat and 
protein metabolism (Adeboye, et al., 2013).  
 
 The symptoms of diabetes include weight loss, 
polydisia (increased thirst), polyuria, (frequent 
urination), polyphagia (increased hunger), and 
lassitude and blurred vision with prusitus vulvae and 
in extreme situation could lead to death.  
 
 Epidemiological studies have shown that 
approximately 5% of world population or estimates 
of 194 million people have diabetes mellitus 
(Donatus, et al., 2014). Modern drugs, including 
insulin and other biochemical agents e.g tolbutamide, 
phenformin, troglitazone, rosigliitazone and 
repaglinide control blood glucose level only when 
they are regularly administered, but these treatments 
are tedious and have several undesirable side effects 
and fail to significantly alter the course of diabetic 
complications (Upadhyay, et al., 1996). 
 
It is therefore imperative for a biomedical research on 
development of hypoglycaemic agent for the control 
of the disease from natural sources to be instituted. 
Some plant products used by the population as 
antidiabetic remedies are edible plants which have 
added further interest in their study because of their 
dual role as food and medicine for the management 
of diabetes. 
 
Some medicinal plants have been associated with the 
management and control of diabetes. There are more 
than 800 plant species with hypoglycaemic activity 
(Donatus, et al., 2014). 
 
The African walnut, botanically called 
Tetracarpidium conophorum is known as “Ukpa” in 
Igbo and “Awusa or “Asala” in Yoruba. It is an 
economic plant widely cultivated for the production 
of nuts used as delicacies (Edem, et al., 2009). Apart 
from consuming as snacks, some studies on the plants 
have revealed that there is good nutritive value in the 
nuts (Akpuaka and Nwankwo, 2000). 
 
The nuts have been shown to cure male infertility 
problems and the leaves are used for the treatment of 
dysentery (Anosike, et al., 2015). The husk has anti-




microbial activity and it is also useful for its anti-
proliferative activity (Okon and Atai, 2014). Anosike, 
et al., (2015) reported that the nuts of T. conophorum 
possess antioxidant activity. 
 
Vernonia amygdalina is commonly called bitter leaf 
because of the characteristics aroma and astrigent 
bitter taste of the leaf. The plant is widely distributed 
in West coast of Africa where it grows wild and as a 
domestic plant (Farombi, 2013). The aqueous leaf 
extract has been shown to possess hypolipidemic 
effects in diabetic and non-diabetic rats. Its protective 
role on kidney and liver of alloxan-induced diabetic 
rat has also been reported (Atangwho, et al., 2007). 
 
Urea is synthesized in the body of many organisms as 
part of the urea cycle, either from the oxidation of 
amino acids or from ammonia. Amino acids from 
ingested food that are not used for the synthesis of 
proteins and other biological substances are oxidized 
by the body, yielding urea and carbon dioxide, as an 
alternative source of energy generation (Sakami, et 
al., 1963). The oxidation pathway starts with the 
removal of the amino group by a transaminase; the 
amino group is then fed into the urea cycle. 
Creatinine is a protein breakdown product and its 
level is a reflection of the bodies muscle mass.  
Creatinine is a metabolite of creatine. Creatinine 
production is endogenous and is determined by 
muscle mass.  Unlike urea, creatinine concentration is 
almost independent of diet.    It increases in renal 
failure (Okoye and Nyimone, 2015; Wootton and 
Freeman, 1982). 
 
The antidiabetic activities of Tetracarpidium 
conophorum nuts and Vernonia amygdalina leaves 
have been reported. In a recent report, the chemical 
components thought to have exerted the antidiabetic 
action were compared (Atangwho, et al., 2009). 
Although extracts from these plants have individually 
demonstrated antidiabetic action, recent studies show 
that antidiabetic efficacy of the extract is enhanced 
when given in combination (Ebong, et al., 2008). In 
this present study, the effects of combined aqueous 
extracts of Tetracaridium conophurm nuts and 
Vernonia amygdalina leaves on some biochemical 
parameters such as urea and creatinine of alloxan 
induced diabetic rats were investigated. 
 
The objective of this research was to investigate the 
effect of the combined aqueous extracts of 
Tetracarpidium conophorum nuts and Vernonia 
amygdalina leaves on blood glucose, serum, amylase 
and renal function using Wistar rats as experimental 
model. 
 
MATERIALS AND METHODS 
Chemicals and Reagents: They include the 
following: Metformin (Merck Serono Ltd. U.K), 
chloroform (BDH chemicals Ltd.), formalin 10%, 
alloxan (Qualkems Lab. Reagents), Biochemical 
reagent kits (MINDRAY) and finisher feed (Top 
Feed Ltd.). 
 
Experimental Animals: Forty two (42) albino rats of 
both sexes weighing between 125g and 275g were 
used for the experiment. They were purchased and 
housed at the Biochemistry Departmental Animal 
House at Choba Campus, University of Port 
Harcourt. They were left for one week to acclimatize 
to the laboratory conditions during which they were 
fed with normal feed (Top feeds- grower´s mash) and 
clean water. The animals were marked for easy 
identification. Three (3) rats were used for pilot 
studies to ascertain that the rats could be made 
diabetic by alloxan treatment at the dose level used 
(120 mg/kg). 
 
Plant Materials: Collection of Plant/ Identification: 
The leaves of Vernonia amygdalina and the nuts of 
Tetracarpidium conophorum were purchased from 
Rumuokoro Market in Obio/Akpor Local 
Government Area, Rivers State. The plant samples 
were identified at the Herbarium of the Plant Science 
and Biotechnology Department, University of Port 
Harcourt, Rivers State, Nigeria.  
 
Preparation of Extract: Tetracarpidium Conophorum 
Extract: The nuts were boiled for one hour –thirty 
minutes and air dried for about 30 minutes. The nuts 
were removed from the shell and ground to coarse 
powder form using a home grinder /blender. Five 
grams of the powdered nut was soaked in 50 ml of 
distilled water for 24 hours after which it was sieved 
using a muslin cloth and afterwards filtered through 
Whatmann Filter Paper. The filtrate was kept in the 
refrigerator until usage. 
 
 Vernonia Amygdalina Extract: The leaves of 
Vernonia amygdalina were washed and shade dried 
at room temperature for seven (7) days, after which 
the leaf powder was prepared using a home grinder. 
Powdered V. amygdalina leaves weighing 5 g was 
soaked in 50 ml of distilled water for 24 hours, after 
which it was sieved using a muslin cloth and 
afterwards filtered through a Whatmann Filter Paper. 
The filtrate was kept in a corked container in the 
refrigerator until usage 
 
Administration of Alloxan: One gramme (1g) of 
Alloxan was dissolved in 20 ml of distilled water 
from which a single dose of 120 mg/kg body weight 




was administered intra-peritoneally to the rats. 
Diabetes was confirmed by ascertaining the glucose 
concentration in the blood of the rats 2-3 days 
following alloxan injection using a glucometer and 
was found to have increased by three to four times 
the normal value. 
Experimental Design: The acclimatized animals were 
sorted into six groups. The diabetic rats were treated 
with Tetracarpidium conophorum extract only, 
Vernonia amygdalina extract only, combined extract 
of T. conophorum and V. amygdalina and Metformin 
a standard antidiabetic drug as shown in the table 
following
: 






The animals in this group are non- diabetic and were given distilled water 
and normal feed throughout the course of this study. 
2 Positive control 
 
The animals in this group were induced with diabetes but were not treated 
with metformin or  the extracts 
3 Diabetic rats 
 
The animals in this group were treated with  
500 mg/kg T. conophorum extract only. 
4 Diabetic rats 
 
The animals in this group were treated with  
500 mg/kg V. amygdalina extract only. 
5 Diabetic rats 
 
The animals in this group were treated with  
500 mg/kg T. conophorum and 500 mg/kg V. amygdalina Extract.  
6 Diabetic rats 
 
The animals in this group were treated with          7. 69 mg/kg Metformin 
only.                                                                                                                              
 
The dosage of metformin was obtained by using the 
standard dose of an average adult which is 500 
mg/65kg body weight. So if 500 mg is for 65 kg, 
therefore 7.69 mg will be for per kg body weight. 
Osinubi, et al. (2007) reported the use of 500 mg/kg 
body weight of V. amygdalina leaves and Okon and 
Atai (2014) reported the use of 500 mg/kg of 
T.conophorum nuts. 
 
Method of Blood and Organ Collection: The blood 
samples used to check for glucose level were 
collected from the tip of the tail of the rats and the 
diabetic rats tested diabetes positive using 
glucometer. Three (3) rats from each of the group 




 day of treatment. 
The animals were anaesthetized using cotton wool 
soaked in chloroform in a desiccator. The 
anaesthetized animals were placed on a dissecting 
slab, the blood sample were collected from the 
jugular vein with lithium –heparin bottles for 
chemistry tests. The blood samples were then taken 
to the laboratory for various analyses. The biggest 
lobe of the liver and the pancreas were cut off with 
surgical blade and placed in a sample bottle 
containing 10% formal- saline solution for 
histological examination. 
 
Plasma Creatinine Estimation: Method: Modified 
Jaffé method according to Bartels and Bohmer (1971) 
was used to determine the level of creatinine in the 
samples. Mindray test kits  was used for the analysis.  
Reaction Principle 
 
Creatinine + Picric acid ↔ Creatinine-Picric acid 
complex 
 
At an alkaline solution, creatinine combines with 
picric acid to form an orange-red colored complex. 
The absorbance increase is directly proportional to 
the concentration of creatinine.  
 
Procedure: Two test tubes labeled T1 (reagent blank) 
and T2 (test sample) were set up. T1 contained 180 
µL of reagent (R1) and 18 µL of distilled water, while 
T2 contained 180 µL of reagent (R1) and 18 µL of 
test sample. The contents of each tube were mixed 
thoroughly at 37℃ for 1 min.  After incubating, 180 
µL of the second reagent (R 2) was added to both test 
tubes. The content of the tube was mixed thoroughly, 
incubated at 37℃ for 30 seconds and the absorbance 
read at 492 nm wavelength 2 minutes later. 
Calculation 
 
∆A = [∆A sample]- [∆A blank]; Conc. of creatinine   
= [change in absorbance of sample] – [change in 
absorbance of blank]., The result is expressed in 
mmol/L. 
 
Plasma Urea Estimation: Method 
Urease-glutamate dehydrogenase -UV method 
according to Berthelot’s method (Weatherburn, 1967) 
was used to determine the level of Urea in the 
samples. Mindray test kits  was used for the analysis.  
Reaction Principle 
 
Urea + H2O2 ↔ 2NH4
+





 + NADH↔  L-Glutamate + 
NAD
+
 + H2O 
 




Urea is hydrolyzed by urease, and one of the 
products, ammonia, oxidises NADH to NAD
+
  
catalysed by glutamate dehydrogenase (GLDH). The 
absorbance decrease is directly proportional to the 
concentration of urea. 
 
Procedure 
Two test tubes labeled T1 (reagent blank) and T2 
(test sample) were set up. T1 contained 1000 µL of 
reagent (R1) and 10 µL of distilled water, while T2 
contained 1000 µL of reagent (R1) and 10 µL of test 
sample. The contents of each tube were mixed and 
incubated at 37℃ for 2 min.  After incubating, 250 
µL of the second reagent (R2) was added to both test 
tubes. The contents of each tube was incubated again 
for 30 seconds at 37℃, the absorbance was read after 
2 minutes at a wavelength of 546 nm. 
Calculation 
 
∆A = [∆A sample]- [∆A blank],Conc. of urea   = 
[change in absorbance of sample] – [change in 
absorbance of blank]., The result is expressed in 
mmol/L. 
 
Assay of amylase activity in the serum.  Method: 
Enzymatic method for estimating amylase activity by 
Rauscher and Buelow (Rauscher, et al., 1982; 
Rauscher, et al., 1985) was used to determine the 
plasma amylase concentration in the samples. This 
method is in accordance with the continuous 
monitoring of recommendations on the IFCC 
(International Federation of Clinical Chemistry). 
Mindray test kit was used for the analysis.  
Reaction Principle 
 
4,6-Benzylidene-G7PNP → Benz-G (7-n) + PNP-
Oligosaccharide 
 
PNP-Oligosaccharide →  Glucose + PNP-Glucoside; 
PNP-Glucoside → p-Nitrophenol + Glucose; (PNP= 
p-Nitrophenol; G= α-Glucose) 
 
In the assay reaction, the substrate 4, 6- Benzylidene-
(G7)-1, 4-nitrophenyl-(G1) –α, D-maltoheptaoside 
(EPS-G7) is cleaved by α-amylases and 
Glucoamylase and subsequent hydrolysis of all the 
degradation products to p-Nitrophenol with the aid of 
α-glucosidase (100% chromophore liberation). The 
increase in absorbance of the p-nitrophenol formed at 
405 nm is directly proportional to the activity of α-
amylases in the sample.  
Procedure 
 
Two test tubes labeled T1 (blank) and T2 (test sample) 
were set up. The reagent was incubated for 2-3 
minutes at 37℃. T1 contained only distilled water 
which serves as the blank, while T2 contained 500 µL 
of reagent and 10 µL of test sample and mixed.  The 
test tube content was emptied into a measuring 
cuvette and the absorbance read after 1,2,3,4, and 5 
minutes at a wavelength of 405 nm. 
 
Calculation: Estimate the ∆A/min. for every reading 
and find the mean value. Conc. of amylase = 
(∆A405nm /min.) x 3178; (∆A405nm /min.) = change in 
absorbance per minute and the result is expressed in 
U/L. 
 
 Histopathological Analysis:  The pancreas were cut 
off and placed in a sample holder containing 10% 
formal saline. The tissues were placed in increasing 
strengths of ethanol for dehydration. The tissues were 
first placed in 70% ethanol for 1
1/
2 hr. The tissues 
were then transferred to 95% ethanol for 1
1/
2 hr. They 
were then transferred to another bath of 95% ethanol 
for 1
1/
2 hr. The tissues were then transferred to three 
baths of absolute ethanol, the tissues lasting in each 
bath for 1
1/
2 hr. The tissues were cleared in xylene (2 
baths for 1 hour each). The tissues were infiltrated 
with 2 baths of molten paraffin wax for 2 hours. They 
were then embedded in paraffin wax using 
embedding rings. Tissue blocks were placed at 4°C 
for 15 minutes to solidify. Five micrometer sections 
of the tissues were cut using microtome. Cut sections 
were placed in a 45°C water bath and placed on a 
slide. Slides were allowed to dry in a 37°C oven 
overnight before staining. 
  
The tissues were stained using Haematoxylin and 
Eosin stains. The tissues for staining were dewaxed 
using xylene and hydrated using decreasing strengths 
of alcohol (absolute, 95%, 70%, 50%). The tissues 
were then immersed in water for complete hydration. 
The tissues were stained with haematoxylin for 20 
minutes. The tissues were washed thoroughly in 
running tap water. The tissues were differentiated in 
acid-alcohol until only the cell nuclei retained the 
stain. The tissues were then blued in Scotts tap water 
substitute for 1 minutes followed by running tap 
water. The tissues were counterstained in Eosin for 2 
minutes. The tissues were washed in running water 
until excess eosin is removed. The tissues were 
dehydrated in increasing strengths of alcohol (50%, 
70%, 95% and absolute). There were then cleared in 
xylene and mounted in DPX ready for microscopic 
examination (Young, 2006). 
 
Statistical Analysis: All data were subjected to 
statistical analysis. Values are reported as mean ± 
standard error of mean (SEM) while one way 
ANOVA was used to test for differences between 
treatment groups. The results were considered 




significant at p-values of less than 0.05, that is, at 
95% confidence level (p<0.05). 
RESULTS AND DISCUSSION 
 
From the glucose result represented in figure 1, it was 
observed that there was a significant (p<0.05) 
increase on the glucose level  of the diabetic group 
compared to other  treated groups which showed a 
significant (p< 0.05) decrease in glucose level as 
treatment progressed. Biochemical parameters such 
as glucose level, amylase level, urea and creatine 
were analyzed to determine their concentration in the 
various samples. The results obtained are shown in 
figures 1 to 4. 
 
 
Fig 1:   The effect of combined  aqueous extracts of 
Tetracarpidium conophorum nuts and Vernonia 
amygdalina  leaves on glucose level of alloxan – 
induced diabetic rats. KEY: NORMAL= Non diabetic; 
DIABETIC= Diabetic & untreated; TCE= Treated with 500 
mg/kg Tetracarpidium conophorum extract; VAE= Treated with 
500 mg/kg Vernonia amygdalina extract; TCE & VAE= Treated 
with 500 mg/kg Tetracarpidium conophorum and 500 mg/kg 
Vernonia amygdalina extract. METFORMIN= Treated with 7.69 
mg/kg metformin. 
 
On day 28, significant difference (p<0.05) was 
observed when  diabetic group was compared with 
the treated groups. Thus, there was a decrease in the 
blood glucose level in all the treated groups.  Also 
there was no significant difference when the group 
treated with the combined extracts of Tetracarpidium 
conophorum and Vernonia amygdalina were 
compared with the group treated with metformin a 
standard drug both on day 14 and day 28 of 
treatments. 
 
As shown in figure 3, it was observed that there was 
a significant increase (p<0.05) on the creatinine level 
of the diabetic untreated group on day 14 when 
compared with other treated groups which showed a 
significant (p<0.05) decrease. On day 28, the groups 
treated with Vernonia amygdalina extract and 
metformin showed a significant (p<0.05) decrease   
when compared to the   group treated with 
Tetracarpidiun conophorum extract.   
 
Fig 2: The effect of combined aqueous extracts of 
Tetracarpidium conophorum nuts and Vernonia 
amygdalina leaves on plasma urea level of alloxan 
induced diabetic wistar rats. KEY: NORMAL= Non 
diabetic; DIABETIC= Diabetic & untreated; TCE= Treated with 
500 mg/kg Tetracarpidium conophorum extract; VAE= Treated 
with 500 mg/kg Vernonia amygdalina extract; TCE & VAE= 
Treated with 500 mg/kg Tetracarpidium conophorum and 500 
mg/kg Vernonia amygdalina extract. METFORMIN= Treated 
with 7.69 mg/kg metformin. 
 
As shown in figure 2, it was observed that there was 
a significant (p<0.05) increase in the urea level of the 
diabetic group (untreated animals, when compared 
with that of other treated groups which showed a 
significant (p<0.05) decrease. On day 28, the group 
treated with combined extracts of Tetracarpidium 
conophorum and Vernonia amygdalina was in close 
range with the group treated with metformin. 
 
 
Fig 3: The effect of combined aqueous extracts of 
Tetracarpidium conophorum nuts and Vernonia 
amygdalina leaves on plasma creatinine level of 
Alloxan induced diabetic wistar rats. KEY: NORMAL= 
Non diabetic; DIABETIC= Diabetic & untreated; TCE= Treated 
with 500 mg/kg Tetracarpidium conophorum extract; VAE= 
Treated with 500 mg/kg Vernonia amygdalina extract; TCE & 
VAE= Treated with 500 mg/kg Tetracarpidium conophorum and 
500 mg/kg Vernonia amygdalina extract. METFORMIN= 





















































As shown in figure 3, it was observed that there was 
a significant increase (p<0.05) on the creatinine level 
of the diabetic untreated group on day 14 when 
compared with other treated groups which showed a 
significant (p<0.05) decrease. On day 28, the groups 
treated with Vernonia amygdalina extract and 
metformin showed a significant (p<0.05) decrease   
when compared to the   group treated with 
Tetracarpidiun conophorum extract.   
 
 
Fig 4: The effect of combined aqueous extracts of 
Tetracarpidium conophorum nuts and Vernonia 
amygdalina leaves on plasma amylase level of 
Alloxan induced diabetic wistar rats. KEY: NORMAL= 
Non diabetic; DIABETIC= Diabetic & untreated; TCE= Treated 
with 500 mg/kg Tetracarpidium conophorum extract; VAE= 
Treated with 500 mg/kg Vernonia amygdalina extract; TCE & 
VAE= Treated with 500 mg/kg Tetracarpidium conophorum and 
500 mg/kg Vernonia amygdalina extract. METFORMIN= 
Treated with 7.69 mg/kg metformin. 
 
As shown in figure 4, it was observed, that there was 
a significant increase (p<0.05) on the amylase level 
of the diabetic untreated group when compared with 
other treated groups which showed a significant 
(p<0.05) decrease. 
 
On day 14, there was a significant decrease on the 
amylase level of the group treated with 
Tetracarpidium conophorum extract when compared 
to the group treated with combined extracts of 
Tetracarpidium conophorum and Vernonia 
amygdalina. Also on day 28, there was a significant 
decrease on the amylase level of the group treated 
with Tetracarpidium conophorum extract when 













Plate A: Photomicrograph of the pancreas of the control rat after 14 days of treatment, stained with haematoxylin and eosin (x40) showing 
normal pancreas. Plate B: Photomicrograph of the pancreas of the diabetic control rat after 14 days of treatment stained with haematoxylin 
and eosin (x40) howing reduced endocrine pancreatic cell. mass with evidence of cytolysis Plate C: Photomicrograph of the pancreas of the 
rat treated with 500 mg/kg TCE and 500 mg/kg VAE after 14 days of treatment stained with haematoxylin and eosin  (x40) showing 
increased endocrine pancreatic cell mass and normal cellular architecture. Plate D: Photomicrograph of the pancreas of the rat treated with 
7.69mg/kg metformin after 14 days of treatment stained with haematoxylin and eosin  ( x40) showing increased endocrine pancreatic cell 
mass and normal cellular architecture Plate E: Photomicrograph of the pancreas of the control rat after 28 days of treatment stained  with 
haematoxylin and eosin (x40) showing normal endocrine pancreas. Plate F: Photomicrograph of the pancreas of the diabetic control rat 
after 28 days of treatment stained with haematoxylin and eosin (x40) showing reduced endocrine pancreatic cell mass with cytolysis and 
mononuclear inflammatory cells infiltration. Plate G:  Photomicrograph of the pancreas of the rat treated with 500 mg/kg TCE and 500 
mg/kg VAE after 28 days of treatment stained haematoxylin and eosin (x40) showing increased endocrine pancreatic cell mass. 
 
 
The consumption of Tetracarpidium conophorum and 
Vernonia amygdalina extract by diabetic rats can 
have a lot of effects on the glucose level, amylase 
level, urea and creatinine levels. There had been 
reports on the effect of Tetracarpidium conophorum 
and Vernonia amygdalina individually on these 
biochemical parameters on alloxan-induced diabetic 
rats. 
 
This work was aimed at assessing the effects of the 
combined treatment or synergistic effect of aqueous 
extracts of Tetracarpidium conophorum nuts and 
Vernonia amygdalina leaves on the glucose level, 
amylase level, urea and creatinine levels on alloxan 
induced diabetic rats. The pancreas was assessed to 
know the extent of damage and effect of the 
combined treatment of these plant extracts in healing 
the damaged pancreas using diabetic Wistar rats as 
experimental model. 
 
From the results of the glucose level, it was observed 
that there was a significant (p<0.05) increase in the 
glucose level of the diabetic untreated animals when 
compared to treated animals which have significant 






















On Day 28, there was a significant (p<0.05) increase 
when the untreated animals were compared with the 
treated animals but most effective and efficient in the 
group treated with combined extracts of 
Tetracarpidium conophorum and Vernonia 
amygdalina, these combined extract competed 
favorably with the reference drug metformin. This 
result agreed with the advantages of polyherbal 
articulated by Tiwari and Rao (2002). 
 
In addition to the antidiabetic properties of these 
plants, each of the plants have been reported of 
different activity geared towards alleviation of 
complication usually associated with diabetes. The 
findings of this present study also confirmed that 
Tetracarpidium conophorum extract alone and 
Vernonia amygdalina extract alone reduce blood 
glucose level significantly (p<0.05) on alloxan 
induced diabetic rats. This can be attributed to the 
bioactive molecules present in the indigenous plants. 
This report is in accordance with that of Donatus, et 
al. (2014) which reported the antihyperglycaemic 
effect of Tetracarpidium conophorum nuts on alloxan 
induced diabetic female albino rats. Ukpabi, et al. 
(2015) also reported the hypoglycaemic effect of 
Vernonia amygdalina on alloxan induced diabetic 
rats. Ayoola, et al. (2011) reported the presence of 
tannins, saponins, alkaloids, phenols and oxalate on 
Tetracarpidium conophorum nut. According to 
Ukpabi, et al. (2015), Vernonia amygdalina is rich in 
alkaloid, tannins, saponins, flavonoids and 
glycosides. Secondary metabolites of plants such as 
the ones listed above possess some alpha-glucosidase 
inhibitors and competively inhibit intestinal brush 
border enzymes with an eventual reduction in 
digestion and absorption of carbohydrates from the 
gut-postprandial hyperglycemia, hence resulting in an 
effective glucose control (Tiwari and Rao, 2002). A 
positive correlation has also been indicated between 
the presence in plants of flavonoids, glycosides and 
phytosterols with hypoglycaemic and anti-
hyperglycaemic actions (Ekeocha, et al., 2012). The 
two plants have bitter taste which could be due to the 
presence of phytochemicals such as alkaloids, 
saponins, tannins and glycoside. The hypoglycaemic 
effect observed in the present study could be due to 
depression of key gluconeogenic or the increase in 
the levels of glucose transport and stimulation of 
uptake in peripheral tissues (Ji Su, et al., 2006). It 
could as well be that these plant extracts may have 
the potential of preserving the cells of islets of 
langerhans, which in turn result in an increase in 
insulin activity (Kamiya, et al., 2008; Yoshikawa, et 
al., 1995; Hossain, et al., 1992). 
 
The inhibition of α-glucosidase and pancreatic α-
amylase activity result in delaying carbohydrate 
digestion to absorbable monosaccharide, causing 
reduction of post prandial hyperglycemia. In diabetic 
condition, amylase is very high as it degrades long 
chain carbohydrate complexes into simpler glucose, 
maltose and other absorbable monosaccharides. From 
the result, it was observed that there was a significant 
increase in amylase level of the diabetic control when 
compared with other treated groups which showed a 
significant decrease. The group treated with 
Tetracarpidium conophorum extract showed the 
lowest value of amylase level and there was a 
significant decrease (p<0.05) when compared with 
the group treated with metformin a standard drug. 
This finding may be as result of phenolic compounds 
contained in Tetracarpidium conophorum. Published 
research suggests that there is a direct relationship 
between the phenolic compounds, flavonoids and 
condensed tannins and the ability to inhibit α-
glucosidase and α-amylase activities (Adisakwattana, 
et al., 2009; Lee, et al., 2007; Mai, et al., 2007). 
 
There was a significant increase (p<0.05) on the urea 
and cretinine levels of the diabetic group when 
compared with other groups which showed a 
significant (p<0.05) decrease. Plasma level of urea 
and creatinine are primarily used to determine the 
efficiency of the kidney. Urea and creatinine 
accumulate in the plasma when renal excretion is 
reduced. Causes of increased blood urea levels 
include high protein diet, intestinal haemorrhage, 
dehydration, severe haemorrhage, shock etc. Urea 
level could be decreased due to the following: liver 
failure, low protein diet, anabolic steroids, diabetes 
insipidus etc (Bush, 1991). In this present study, the 
combined extracts of Tetracarpidium conophorum 
and Vernonia amygdalina were able to reduce the 
plasma levels of urea and creatinine, this is an 
indication that the extracts possess the potentials of 
ameliorating renal failure.  
 
The histological examination of the pancreas of the 
diabetic control rat on day 14 showed reduced 
endocrine pancreatic cell mass with evidence of 
cytolysis compared to that of the rat that was treated 
with 500 mg/kg TCE and 500 mg/kg VAE which 
showed increased endocrine cell mass and normal 
cellular architecture. 
On day 28, the histology examination of the pancreas 
of the diabetic control rat showed reduced endocrine 
pancreatic cell mass with cytolysis and mononuclear 
inflammatory cells infiltration compared to that of the 
rat that received 500 mg/kg TCE and 500 mg/kg 
VAE which showed mild to moderate cytolysis of the 
endocrine pancreas with residual increase in cell 




mass. From these changes observed in the 
histological examination of the pancreas, it can be 
inferred that the combined aqueous extracts of 
Tetracarpidium conphorum nuts and Vernonia 
amygdalina leaves were able to ameliorate the 
damage caused by alloxan. 
 
Conclusion: The present work indicated that the 
combined aqueous extracts of Tetracarpidium 
conophorum nuts and Vernonia amygdalina leaves 
reduced the level of damage to the kidney and 
pancreas when administered to diabetic rats at the 
dosage used in this study. 
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